Technology News and Research

RSS

GE Healthcare to showcase molecular imaging portfolio at WMIC

Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.

10 Sep 2010

Dow Jones Sustainability World Index renews inclusion of Bayer

Bayer stock has been included once again in the Dow Jones Sustainability World Index (DJSI World), providing renewed proof of the standing of the company as an international leader in sustainability. Bayer is thus one of very few companies headquartered in Germany to have been listed in the DJSI World without interruption since the establishment of the index in 1999.

10 Sep 2010

FDA issues warning letters to five electronic cigarette distributors

The U.S. Food and Drug Administration today issued warning letters to five distributors for various violations of the Federal Food, Drug, and Cosmetic Act (FDCA) including unsubstantiated claims and poor manufacturing practices.

10 Sep 2010

Translational Research issue focuses field of stem cell research, therapy

The use of stem cells for research and their possible application in the treatment of disease are hotly debated topics. In a special issue of Translational Research published this month an international group of medical experts presents an in-depth and balanced view of the rapidly evolving field of stem cell research and considers the potential of harnessing stem cells for therapy of human diseases including cardiovascular diseases, renal failure, neurologic disorders, gastrointestinal diseases, pulmonary diseases, neoplastic diseases, and type 1 diabetes mellitus.

10 Sep 2010

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.

10 Sep 2010

Summit negotiators seek to get MDGs 'back on track'

"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.

10 Sep 2010

Tornier pyrocarbon shoulder prostheses reduce patient pain, offered shorter recovery time

Tornier, Inc., a global leader in extremity and sports medicine orthopaedics, announced today the successful early clinical results of the first seven pyrocarbon shoulder prostheses that were implanted between April 2009 and December 2009.

10 Sep 2010

Special journal issue highlights obsessive compulsive disorder and Tourette's disorder therapies

Pediatric onset obsessive compulsive disorder (OCD) and Tourette's disorder (TD) share similarities in their underlying genetic and environmental factors, psychiatric features, and treatment methods. Advances in understanding the neurobiological basis of these disorders and discovering new and more effective therapies are highlighted in a special issue on OCD and TD in Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

10 Sep 2010

ASNM to hold annual conference on nanomedicine

There is enormous excitement and expectation surrounding the multidisciplinary field of nanomedicine the science and technology of diagnosing, treating and preventing disease using nanotechnology. The American Society for Nanomedicine (ASNM) is holding its second annual conference on October 14-16, 2010 in the Washington, D.C. area, where some of the biggest stakeholders in this emerging technology operate and practice.

10 Sep 2010

USPTO issues patent for Advaxis’ live Listeria HER2/neu immunotherapy

The U.S. Patent and Trademark Office has issued to Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent number 7,784,729 titled "Methods and Compositions for Immunotherapy of Cancer," based upon patent application 10/949,667.

10 Sep 2010

Researchers to develop two-way fiber optic communication between prosthetic limbs and peripheral nerves

Lightning fast connections between robotic limbs and the human brain may be within reach for injured soldiers and other amputees with the establishment of a multimillion-dollar research center led by SMU engineers.

10 Sep 2010

FDA approves Abreu BTT 700 System for temperature monitoring

Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.

10 Sep 2010

PracticeMax acquires Medinomics, expands healthcare and technology expertise

PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired Medinomics, of Shreveport, La., expanding the operations and geographical footprint of PracticeMax throughout the southern United States.

10 Sep 2010

National Dementia Awareness Week

This National Dementia Awareness Week 15-22 September, Alzheimer’s Australia and National Dementia Awareness Week Ambassador, Dr Andrew Rochford will be promoting the benefit of early diagnosis and where worried friends and family can access help.

9 Sep 2010

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £2.5 million through a rights issue to existing investors. The round was significantly oversubscribed and completed within four weeks.

9 Sep 2010

NovaSterilis issued US patent

NovaSterilis Inc. has been issued US Patent # 7,771,652 B2 for “Combined Use of an Alkaline Earth Metal Compound and a Sterilizing Agent to Maintain Osteoinduction Properties of a Demineralized Bone Matrix”

9 Sep 2010

Roche announces Ambry Genetics as first US CSP for NimbleGen SeqCap EZ Exome workflow

Roche NimbleGen announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for the NimbleGen SeqCap EZ Exome workflow. They will provide target-enrichment services using NimbleGen SeqCap EZ Human Exome coupled with next-generation sequencing services for genetic research.

9 Sep 2010

Affinity Health System selects GE Centricity EMR for patient care network

Northeast Wisconsin's nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley's Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.

9 Sep 2010

3M to acquire Arizant for $810M

3M announced today it has entered into a definitive agreement to acquire Arizant Inc. for a purchase price of $810 million in cash. Based in Eden Prairie, Minn., Arizant is a leading manufacturer of patient warming solutions designed to prevent hypothermia in surgical settings.

9 Sep 2010

Huifeng Bio-Pharmaceutical Technology to acquire Shangqiu Kexin Rutin Processing

Huifeng Bio-Pharmaceutical Technology, Inc., specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announces a definitive agreement under which Huifeng will acquire 90% of the equity ownership of Shangqiu Kexin Rutin Processing Ltd., a local leading Rutin manufacturer in Henan Province, at a price of $1.75 million. As a result of the acquisition, Kexin will be a wholly-owned subsidiary of Huifeng.

9 Sep 2010

Technology News and Research

GE Healthcare to showcase molecular imaging portfolio at WMIC

Dow Jones Sustainability World Index renews inclusion of Bayer

FDA issues warning letters to five electronic cigarette distributors

Translational Research issue focuses field of stem cell research, therapy

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Summit negotiators seek to get MDGs 'back on track'

Tornier pyrocarbon shoulder prostheses reduce patient pain, offered shorter recovery time

Special journal issue highlights obsessive compulsive disorder and Tourette's disorder therapies

ASNM to hold annual conference on nanomedicine

USPTO issues patent for Advaxis’ live Listeria HER2/neu immunotherapy

Researchers to develop two-way fiber optic communication between prosthetic limbs and peripheral nerves

FDA approves Abreu BTT 700 System for temperature monitoring

PracticeMax acquires Medinomics, expands healthcare and technology expertise

National Dementia Awareness Week

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

NovaSterilis issued US patent

Roche announces Ambry Genetics as first US CSP for NimbleGen SeqCap EZ Exome workflow

Affinity Health System selects GE Centricity EMR for patient care network

3M to acquire Arizant for $810M

Huifeng Bio-Pharmaceutical Technology to acquire Shangqiu Kexin Rutin Processing

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News